Keywords: johnson, buy, tibotec-virco, belgium, million, deal, signed
Johnson & Johnson to buy Tibotec-Virco of Belgium in $320 million deal
Article | 01 April 2002
Johnson & Johnson has signed a definitive agreement to acquire all ofthe assets of Tibotec-Virco NV, a privately-held Belgium-headquartered biopharmaceutical company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
